Photo of Steven J. Schnelle

Steven Schnelle focuses his practice on regulatory and transactional matters involving health care providers and suppliers, pharmacies, pharmaceutical firms, device manufacturers, and market innovators. Read Steven Schnelle's full bio.

The US District Court for the District of Columbia recently held that the Centers for Medicare and Medicaid Services (CMS) exceeded its authority by reducing Medicare payment rates for 340B drugs, but, because of the budget-neutral nature of the cuts, the court left implementation details of its order temporarily unresolved to avoid disrupting administration of the Medicare Hospital Outpatient Prospective Payment System. It remains to be seen what remedies the court will ultimately order and whether CMS will appeal the decision.

Access the full article.